-

Inphi Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Inphi Corporation Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – IPHI

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Inphi Corporation (NASDAQ: IPHI) to Marvell Technology Group Ltd. (“Marvell”) is fair to Inphi shareholders. Under the terms of the merger agreement, Inphi shareholders will receive $66.00 in cash and 2.323 shares of the combined company’s stock for each Inphi share. On behalf of Inphi shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

If you are an Inphi shareholder and would like to discuss your legal rights and options, please visit Inphi Merger or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

The Inphi merger investigation concerns whether Inphi and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to: (1) obtain the best possible price for Inphi shareholders; (2) determine whether Marvell is underpaying for Inphi; and (3) disclose all material information necessary for Inphi shareholders to adequately assess and value the merger consideration.

If you are an Inphi shareholder and would like to discuss your legal rights and options, please visit https://halpersadeh.com/actions/inphi-corporation-iphi-stock-merger-marvell/ or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contacts

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Halper Sadeh LLP

NASDAQ:IPHI

Release Versions

Contacts

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

More News From Halper Sadeh LLP

LCII Stock Alert: Halper Sadeh LLC is Investigating Whether LCI Industries is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of LCI Industries (NYSE: LCII) to Patrick Industries, Inc. for 1.2440 shares of Patrick common stock for each share of LCI Industries common stock.Halper Sadeh encourages LCI Industries shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.The investigati...

PATK Stock Alert: Halper Sadeh LLC is Investigating Whether Patrick Industries, Inc. is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Patrick Industries, Inc. (NASDAQ: PATK) and LCI Industries. Upon completion of the proposed transaction, Patrick shareholders will own approximately 52% of the combined company. Halper Sadeh encourages Patrick shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@h...

TBPH Stock Alert: Halper Sadeh LLC is Investigating Whether Theravance Biopharma, Inc. is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Theravance Biopharma, Inc. (NASDAQ: TBPH) to Zymeworks Inc. for $17.00 per share. Halper Sadeh encourages Theravance shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Theravance and its board of directors violat...
Back to Newsroom